Date: 21-Aug-2019

Dr Reddys launches generic oral anti-epileptic drug in US

Drug firm Dr Reddys Laboratories on Tuesday said it has launched generic anti-epileptic Vigabatrin powder for oral solution in the US market. The product is a generic version of Lundbecks Sabril powder for oral solution, Dr Reddys said in a filing to the BSE. The company has launched Vigabatrin powder for oral solution, USP in 500 mg per packet after getting approval by the United States Food and Drug Administration (USFDA), it said.